Compounds > carmustine

carmustine and indazoles

carmustine has been researched along with indazoles in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hahn, GM; Ning, SC1
Epelbaum, R; Frei, E; Herman, TS; Holden, SA; Liu, SD; Teicher, BA1
Dezube, B; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA1
Codacci Pisanelli, G; Franchi, F; Giovagnorio, F; Gualdi, G; Guazzugli Bonaiuti, VP; Seminara, P1
Bearzatto, A; Costa, A; Orlandi, L; Silvestrini, R; Villa, R; Zaffaroni, N1
Biroccio, A; D'Angelo, C; Del Bufalo, D; Laudonio, N; Sacchi, A; Soddu, S; Zupi, G1

Other Studies

6 other study(ies) available for carmustine and indazoles

ArticleYear
Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
    Cancer research, 1991, Nov-01, Volume: 51, Issue:21

    Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Combined Modality Therapy; Fibrosarcoma; Fluorouracil; Hyperthermia, Induced; Indazoles; Male; Mice; Mice, Inbred C3H; Neoplasms, Radiation-Induced; Sarcoma, Experimental

1991
Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Cancer research, 1991, Feb-01, Volume: 51, Issue:3

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Carmustine; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Fibrosarcoma; Humans; Indazoles; Mammary Neoplasms, Animal; Mice; Organoplatinum Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay

1991
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
    International journal of cancer, 1991, Jun-19, Volume: 48, Issue:4

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cisplatin; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Fibrosarcoma; Hematopoietic Stem Cells; Indazoles; Male; Melphalan; Mice; Mice, Inbred C3H; Pentoxifylline; Sarcoma, Experimental

1991
Elevated doses of carmustine and mitomycin C, with lonidamine enhancement and autologous bone marrow transplantation in the treatment of advanced colorectal cancer: results from a pilot study.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:10

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Indazoles; Male; Middle Aged; Mitomycin; Pilot Projects; Rectal Neoplasms; Survival Analysis

1994
In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Cell Cycle; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Indazoles; Mitomycin; Tumor Cells, Cultured

1994
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
    The Journal of clinical investigation, 1996, Sep-01, Volume: 98, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carmustine; Cell Line; Doxorubicin; Drug Resistance; Female; Glioblastoma; Humans; Indazoles; Treatment Failure; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1996